- Home
- QNCX vs MRAM Comparison
QNCX vs MRAM Comparison
Compare QNCX & MRAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- MRAM
- Stock Information
- Founded
- QNCX 2012
- MRAM 2008
- Country
- QNCX United States
- MRAM United States
- Employees
- QNCX 36
- MRAM N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- MRAM Semiconductors
- Sector
- QNCX Health Care
- MRAM Technology
- Exchange
- QNCX Nasdaq
- MRAM Nasdaq
- Market Cap
- QNCX 139.2M
- MRAM 150.5M
- IPO Year
- QNCX 2019
- MRAM 2016
- Fundamental
- Price
- QNCX $2.68
- MRAM $7.78
- Analyst Decision
- QNCX Strong Buy
- MRAM Strong Buy
- Analyst Count
- QNCX 4
- MRAM 1
- Target Price
- QNCX $7.75
- MRAM $10.50
- AVG Volume (30 Days)
- QNCX 551.1K
- MRAM 251.3K
- Earning Date
- QNCX 11-12-2025
- MRAM 11-05-2025
- Dividend Yield
- QNCX N/A
- MRAM N/A
- EPS Growth
- QNCX N/A
- MRAM N/A
- EPS
- QNCX N/A
- MRAM N/A
- Revenue
- QNCX N/A
- MRAM $53,642,000.00
- Revenue This Year
- QNCX N/A
- MRAM $10.80
- Revenue Next Year
- QNCX N/A
- MRAM $13.42
- P/E Ratio
- QNCX N/A
- MRAM N/A
- Revenue Growth
- QNCX N/A
- MRAM N/A
- 52 Week Low
- QNCX $0.72
- MRAM $4.34
- 52 Week High
- QNCX $2.85
- MRAM $12.27
- Technical
- Relative Strength Index (RSI)
- QNCX 83.72
- MRAM 36.87
- Support Level
- QNCX $1.61
- MRAM $7.35
- Resistance Level
- QNCX $1.84
- MRAM $8.42
- Average True Range (ATR)
- QNCX 0.21
- MRAM 0.50
- MACD
- QNCX 0.10
- MRAM -0.16
- Stochastic Oscillator
- QNCX 87.94
- MRAM 17.81
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).